KRAS and central nervous system cancer: GSEA identified several oncogenic pathways significantly enriched in the CIC-mutant oligodendrogliomas (Figure S3G) of which K-Ras signaling was significantly upregulated (Supplementary Figure 3H), corroborating the observation that CIC antagonizes Ras signaling and proliferation in glioma.